Given the association between SLC39A14 and ATP13A2 and the similarities in immune and prognostic profiles, we hypothesize that ATP13A2 may promote tumour progression through an ion channel mechanism similar to SLC39A14, which may cooperate with other genes. Here, ATP13A2 is linked to neoplasm.